Autor: Richard D. Gelber

This RRCR-conference-volume marks "number six" in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 e …

We often hear physicians, health care professionals, poli- ticians, and patient advocates that "nothing has happened in the treatment of breast cancer, " since patients with breast cancer, …

The ultimate "consumer" of the data presented at conferences on the primary treatment of operable breast cancer is the patient, and when, as in this disease, the benefits of therapy are rel …

Advances in breast cancer research, achieved through the progress of knowledge and development of new therapies, have been translated into improved quality of care for breast cancer patients. Clinica …